U.S. flag

An official website of the United States government

New/Reinstated & Terminated Labeler Information

The information below identifies new/reinstated & terminated labelers. This page will be updated as new information is available so please check back often.

For definitions of optional and mandatory effective dates, please see the Medicaid National Drug Rebate Agreement (NDRA). Additionally, the Drug Manufacturer Contact Information contains Optional Effective Date, Termination Date (if applicable), and Legal, Invoice and Technical Contact information for each drug company participating in the MDRP. 

New/Reinstated Labelers

Labeler CodeLabeler NameOptional Effective Date (for State Coverage)Mandatory Effective Date (for State Coverage)
83853INTRABIO INC.10/03/202401/01/2025
82580ARS PHARMACEUTICALS OPERATIONS, INC.09/27/202401/01/2025
80005CARNEGIE PHARMACEUTICALS09/20/202401/01/2025
11797ITALFARMACO SPA08/28/202401/01/2025
83205ADAPTIMMUNE, LLC.08/23/202401/01/2025
83745APOZEAL PHARMACEUTICALS INC.08/20/202401/01/2025
61476GC BIOPHARMA USA, INC.07/29/202410/01/2024
83034VERONA PHARMA, INC.07/24/202410/01/2024
82959GERON CORPORATION07/18/202410/01/2024
72960REVANCE THERAPEUTICS, INC.07/18/202410/01/2024
83222ORCHARD THERAPEUTICS (EUROPE) LIMITED06/24/202410/01/2024
81279PANGEA PHARMACEUTICALS, LLC06/20/202410/01/2024
83296X4 PHARMACEUTICALS, INC.06/18/202410/01/2024
83720ONCOR PHARMACEUTICALS, LLC06/07/202410/01/2024
81481ALTOR BIOSCIENCE, LLC06/03/202410/01/2024
29273SALERNO PHARMACEUTICALS LP05/21/202410/01/2024
83831AVYXA PHARMACEUTICALS, LLC05/10/202410/01/2024
82950DAY ONE BIOPHARMACEUTICALS, INC.05/09/202410/01/2024

Terminated Labelers

Labeler CodeLabeler NameEffective Date
24510COLLEGIUM PHARMACEUTICAL, INC.01/01/2025
46017MYLAN CONSUMER HEALTHCARE, INC.01/01/2025
82347YARAL PHARMA INC.10/01/2024
52937AMARIN PHARMACEUTICALS IRELAND LTD10/01/2024
73358CURAE PHARMA360 INC.10/01/2024
73063AMYLYX PHARMACEUTICALS, INC.10/01/2024
71858IBSA PHARMA, INC.10/01/2024
49730HERCON PHARMACEUTICALS, LLC10/01/2024

For questions, please contact MDRP Operations at MDROperations@cms.hhs.gov.

Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on New/Reinstated & Terminated Labelers and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), subsequent program releases, or regulations.

Page last updated on October 4, 2024